Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Millan, MJ' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 141 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Millan, MJ; Brocco, M; Gobert, A; Dorey, G; Casara, P; Dekeyne, A
      Anxiolytic properties of the selective, non-peptidergic CRF1 antagonists, CP154,526 and DMP695: A comparison to other classes of anxiolytic agent

      NEUROPSYCHOPHARMACOLOGY
    2. Audinot, V; Newman-Tancredi, A; Cussac, D; Millan, MJ
      Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT1D receptors

      NEUROPSYCHOPHARMACOLOGY
    3. Dekeyne, A; Rivet, JM; Gobert, A; Millan, MJ
      Generalization of serotonin (5-HT)(1A) agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminativestimuli elicited by PD128,907 and 7-OH-DPAT

      NEUROPHARMACOLOGY
    4. Milligan, G; Kellett, E; Dacquet, C; Dubreuil, V; Jacoby, E; Millan, MJ; Lavielle, G; Spedding, M
      S 14506: novel receptor coupling at 5-HT1A receptors

      NEUROPHARMACOLOGY
    5. Audinot, V; Newman-Tancredi, A; Millan, MJ
      Constitutive activity at serotonin 5-HT1D receptors: detection by homologous GTP gamma S versus [S-35]-GTP gamma S binding isotherms

      NEUROPHARMACOLOGY
    6. Newman-Tancredi, A; Chaput, C; Touzard, M; Millan, MJ
      Pindolol antagonises G-protein activation at both pre- and postsynaptic serotonin 5-HT1A receptors: a [S-35]GTP gamma S autoradiography study

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    7. Millan, MJ; Gobert, A; Lejeune, F; Newman-Tancredi, A; Rivet, JM; Auclair, A; Peglion, JL
      S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    8. Millan, MJ; Dekeyne, A; Papp, M; La Rochelle, CD; Macsweeny, C; Peglion, JL; Brocco, M
      S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    9. Millan, MJ; Cussac, D; Milligan, G; Carr, C; Audinot, V; Gobert, A; Lejeune, F; Rivet, JM; Brocco, M; Duqueyroix, D; Nicolas, JP; Boutin, JA; Newman-Tancredi, A
      Antiparkinsonian agent piribedil displays antagonist properties at native,rat, and cloned, human alpha(2)-adrenoceptors: Cellular and functional characterization

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    10. Millan, MJ; Lejeune, F; De Nanteuil, G; Gobert, A
      Selective blockade of neurokinin (NK)(1) receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats

      JOURNAL OF NEUROCHEMISTRY
    11. Cordi, AA; Berque-Bestel, I; Persigand, T; Lacoste, JM; Newman-Tancredi, A; Audinot, V; Millan, MJ
      Potential antidepressants displayed combined alpha(2)-adrenoceptor antagonist and monoamine uptake inhibitor properties

      JOURNAL OF MEDICINAL CHEMISTRY
    12. Newman-Tancredi, A; Verriele, L; Touzard, M; Millan, MJ
      Efficacy of antipsychotic agents at human 5-HT1A receptors determined by [H-3]WAY100,635 binding affinity ratios: Relationship to efficacy for G-protein activation

      EUROPEAN JOURNAL OF PHARMACOLOGY
    13. Millan, MJ; Newman-Tancredi, A; Duqueyroix, D; Cussac, D
      Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinase

      EUROPEAN JOURNAL OF PHARMACOLOGY
    14. Newman-Tancredi, A; Verriele, L; Millan, MJ
      Differential modulation by GTP gamma S of agonist and inverse agonist binding to h5-HT1A receptors revealed by [H-3]-WAY100,635

      BRITISH JOURNAL OF PHARMACOLOGY
    15. Dekeyne, A; Gobert, A; Iob, L; Cistarelli, L; Melon, C; Millan, MJ
      Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats

      PSYCHOPHARMACOLOGY
    16. Millan, MJ; Newman-Tancredi, A; Quentric, Y; Cussac, D
      The '' selective '' dopamine D-1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin(2C) receptors

      PSYCHOPHARMACOLOGY
    17. Dekeyne, A; Iob, L; Millan, MJ
      Following long-term training with citalopram, both mirtazapine and mianserin block its discriminative stimulus properties in rats

      PSYCHOPHARMACOLOGY
    18. Yang, DL; Kefi, S; Audinot, V; Millan, MJ; Langlois, M
      Benzamides derived from 1,2-diaminocyclopropane as novel ligands for humanD-2 and D-3 dopamine receptors

      BIOORGANIC & MEDICINAL CHEMISTRY
    19. Lejeune, F; Millan, MJ
      Pindolol excites dopaminergic and adrenergic neurons, and inhibits serotonergic neurons, by activation of 5-HT1A receptors

      EUROPEAN JOURNAL OF NEUROSCIENCE
    20. Millan, MJ; Gobert, A; Rivet, JM; Adhumeau-Auclair, A; Cussac, D; Newman-Tancredi, A; Dekeyne, A; Nicolas, JP; Lejeune, F
      Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha(2)-adrenergic and serotonin(2C) receptors: a comparison with citalopram

      EUROPEAN JOURNAL OF NEUROSCIENCE
    21. Gobert, A; Rivet, JM; Lejeune, F; Newman-Tancredi, A; Adhumeau-Auclair, A; Nicolas, JP; Cistarelli, L; Melon, C; Millan, MJ
      Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat

      SYNAPSE
    22. Millan, MJ; Newman-Tancredi, A; Audinot, V; Cussac, D; Lejeune, F; Nicolas, JP; Coge, F; Galizzi, JP; Boutin, JA; Rivet, JM; Dekeyne, A; Gobert, A
      Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT1B, 5-HT1D and dopamine D-2 and D-3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states

      SYNAPSE
    23. Morris, BJ; Newman-Tancredi, A; Audinot, V; Simpson, CS; Millan, MJ
      Activation of dopamine D-3 receptors induces c-fos expression in primary cultures of rat striatal neurons

      JOURNAL OF NEUROSCIENCE RESEARCH
    24. Millan, MJ; Lejeune, F; Gobert, A
      Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents

      JOURNAL OF PSYCHOPHARMACOLOGY
    25. Gobert, A; Dekeyne, A; Millan, MJ
      The ability of WAY100,635 to potentiate the neurochemical and functional actions of fluoxetine is enhanced by co-administration of SB224,289, but notBRL15572

      NEUROPHARMACOLOGY
    26. Newman-Tancredi, A; Chaput, C; Touzard, M; Millan, MJ
      [S-35]-GTP gamma S autoradiography reveals alpha(2) adenoceptor-mediated G-protein activation in amygdala and lateral septum

      NEUROPHARMACOLOGY
    27. Dekeyne, A; Denorme, B; Monneyron, S; Millan, MJ
      Citalopram reduces social interaction in rats by activation of serotonin (5-HT)(2C) receptors

      NEUROPHARMACOLOGY
    28. Millan, MJ; Girardon, S; Monneyron, S; Dekeyne, A
      Discriminative stimulus properties of the dopamine D-3 receptor agonists, PD128,907 and 7-OH-DPAT: a comparative characterization with novel ligands at D-3 versus D-2 receptors

      NEUROPHARMACOLOGY
    29. Cussac, D; Newman-Tancredi, A; Nicolas, JP; Boutin, JA; Millan, MJ
      Antagonist properties of the novel antipsychotic, S16924, at cloned, humanserotonin 5-HT2C receptors: a parallel phosphatidylinositol and calcium accumulation comparison with clozapine and haloperidol

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    30. Cussac, D; Newman-Tancredi, A; Sezgin, L; Millan, MJ
      [H-3]S33084: a novel, selective and potent radioligand at cloned, human dopamine D-3 receptors

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    31. Cussac, D; Newman-Tancredi, A; Quentric, Y; Millan, MJ
      An innovative method for rapid characterisation of phospholipase C activity: SB242,084 competitively antagonises 5-HT2C receptor-mediated [H-3]phosphatidylinositol depletion

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    32. Newman-Tancredi, A; Audinot, V; Moreira, C; Verriele, L; Millan, MJ
      Inverse agonism and constitutive activity as functional correlates of serotonin h5-HT1B receptor/G-protein stoichiometry

      MOLECULAR PHARMACOLOGY
    33. Millan, MJ
      Improving the treatment of schizophrenia: Focus on serotonin (5-HT)(1A) receptors

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    34. Millan, MJ; Dekeyne, A; Newman-Tancredi, A; Cussac, D; Audinot, V; Milligan, G; Duqueyroix, D; Girardon, S; Mullot, J; Boutin, JA; Nicolas, JP; Renouard-Try, A; Lacoste, JM; Cordi, A
      S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    35. Millan, MJ; Lejeune, F; Gobert, A; Brocco, M; Auclair, A; Bosc, C; Rivet, JM; Lacoste, JM; Cordi, A; Dekeyne, A
      S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    36. Millan, MJ; Gobert, A; Newman-Tancredi, A; Lejeune, F; Cussac, D; Rivet, JM; Audinot, V; Dubuffet, T; Lavielle, G
      S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    37. Millan, MJ; Dekeyne, A; Rivet, JM; Dubuffet, T; Lavielle, G; Brocco, M
      S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    38. Millan, MJ; Gobert, A; Bervoets, K; Rivet, JM; Veiga, S; Brocco, M
      Induction of spontaneous tail-flicks in rats by blockade of transmission at N-methyl-D-aspartate receptors: Roles of multiple monoaminergic receptorsin relation to the actions of antipsychotic agents

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    39. Millan, MJ; Gobert, A; Newman-Tancredi, A; Lejeune, F; Cussac, D; Rivet, JM; Audinot, V; Adhumeau, A; Brocco, M; Nicolas, JP; Boutin, JA; Despaux, N; Peglion, JL
      S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: I. Receptorial, neurochemical, and electrophysiological profile

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    40. Millan, MJ; Brocco, M; Rivet, JM; Audinot, V; Newman-Tancredi, A; Maiofiss, L; Queriaux, S; Despaux, N; Peglion, JL; Dekeyne, A
      S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine,and 11 other antipsychotic agents

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    41. Cussac, D; Newman-Tancredi, A; Sezgin, L; Millan, MJ
      The novel antagonist, S33084, and CR218,231 interact selectively with cloned and native, rat dopamine D-3 receptors as compared with native, rat dopamine D-2 receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    42. Millan, MJ; Audinot, V; Honore, P; Bervoets, K; Veiga, S; Brocco, M
      Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    43. Dekeyne, A; Brocco, M; Adhumeau, A; Gobert, A; Millan, MJ
      The selective serotonin (5-HT)(1A) receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats - A comparison with other anxiolytic agents

      PSYCHOPHARMACOLOGY
    44. Dubuffet, T; Newman-Tancredi, A; Cussac, D; Audinot, V; Loutz, A; Millan, MJ; Lavielle, G
      Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D-3 receptor antagonists

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    45. Millan, MJ; Brocco, M; Gobert, A; Joly, F; Bervoets, K; Rivet, JM; Newman-Tancredi, A; Audinot, V; Maurel, S
      Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2A sites for PCP-induced locomotion in the rat

      EUROPEAN JOURNAL OF NEUROSCIENCE
    46. Millan, MJ; Gobert, A; Audinot, V; Dekeyne, A; Newman-Tancredi, A
      Inverse agonists and serotonergic transmission: From recombinant, human serotonin (5-HT)(1B) receptors to G-protein coupling and function in corticolimbic structures in vivo

      NEUROPSYCHOPHARMACOLOGY
    47. Gobert, A; Millan, MJ
      Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone andin association with 5-HT reuptake inhibitors: Comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors

      NEUROPSYCHOPHARMACOLOGY
    48. Gobert, A; Rivet, JM; Cistarelli, L; Melon, C; Millan, MJ
      Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: Activation of serotonin(1A) receptors and blockade of alpha(2)-adrenergic receptors underlie its actions

      NEUROSCIENCE
    49. Millan, MJ
      The induction of pain: An integrative review

      PROGRESS IN NEUROBIOLOGY
    50. Millan, MJ; Gobert, A
      (-)-Pindolol increases dialysate concentrations of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely-moving rats

      NEUROPHARMACOLOGY
    51. Dekeyne, A; Girardon, S; Millan, MJ
      Discriminative stimulus properties of the novel serotonin (5-HT)(2C) receptor agonist, RO 60-0175: a pharmacological analysis

      NEUROPHARMACOLOGY
    52. Gobert, A; Millan, MJ
      Serotonin (5-HT)(2A) receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats

      NEUROPHARMACOLOGY
    53. Newman-Tancredi, A; Cussac, D; Audinot, V; Millan, MJ
      Actions of roxindole at recombinant human dopamine D-2, D-3 and D-4 and serotonim 5-HT1A, 5-HT1B and 5-HT1D receptors

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    54. Cussac, D; Newman-Tancredi, A; Pasteau, V; Millan, MJ
      Human dopamine D-3 receptors mediate mitogen- activated protein kinase activation via a phosphatidylinositol 3-kinase and an atypical protein kinase C-dependent mechanism

      MOLECULAR PHARMACOLOGY
    55. Newman-Tancredi, A; Cussac, D; Audinot, V; Pasteau, V; Gavaudan, S; Millan, MJ
      G protein activation by human dopamine D-3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5 '-O-(3-[S-35]thio)-triphosphate binding and antibody study

      MOLECULAR PHARMACOLOGY
    56. Millan, MJ; Schreiber, R; Monneyron, S; Denorme, B; Melon, C; Queriaux, S; Dekeyne, A
      S-16924, a novel, potential antipsychotic with marked serotonin(1A) agonist properties. IV. A drug discrimination comparison with clozapine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    57. Millan, MJ; Brocco, M; Gobert, A; Schreiber, R; Dekeyne, A
      S-16924 [(R)-2-{1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl}1-(4-fluorophenyl)-ethanone], a novel, potential antipsychotic withmarked serotonin(1A) agonist properties: III. Anxiolytic actions in comparison with clozapine and haloperidol

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    58. Newman-Tancredi, A; Rivet, JM; Chaput, C; Touzard, M; Verriele, L; Millan, MJ
      The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [S-35]GTP gamma S and [H-3]S15535 autoradiography study

      EUROPEAN JOURNAL OF PHARMACOLOGY
    59. Millan, MJ; Gobert, A; Girardon, S; Dekeyne, A
      Citalopram elicits a discriminative stimulus in rats at a dose selectivelyincreasing extracellular levels of serotonin vs. dopamine and noradrenaline

      EUROPEAN JOURNAL OF PHARMACOLOGY
    60. Carli, M; Balducci, C; Millan, MJ; Bonalumi, P; Samanin, R
      S 15535, a benzodioxopiperazine acting as presynaptic agonist and postsynaptic 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine

      BRITISH JOURNAL OF PHARMACOLOGY
    61. Sebban, C; Zhang, XQ; Tesolin-Decros, B; Millan, MJ; Spedding, M
      Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission

      BRITISH JOURNAL OF PHARMACOLOGY
    62. Sebban, C; Tesolin-Decros, B; Millan, MJ; Spedding, M
      Contrasting EEG profiles elicited by antipsychotic agents in the prefrontal cortex of the conscious rat: antagonism of the effects of clozapine by modafinil

      BRITISH JOURNAL OF PHARMACOLOGY
    63. Millan, MJ; Girardon, S; Dekeyne, A
      5-HT2C receptors are involved in the discriminative stimulus effects of citalopram in rats

      PSYCHOPHARMACOLOGY
    64. NEWMANTANCREDI A; CHAPUT C; GAVAUDAN S; VERRIELE L; MILLAN MJ
      AGONIST AND ANTAGONIST ACTIONS OF (-)PINDOLOL AT RECOMBINANT, HUMAN SEROTONIN(1A) (5-HT1A) RECEPTORS

      Neuropsychopharmacology
    65. LEJEUNE F; MILLAN MJ
      INDUCTION OF BURST FIRING IN VENTRAL TEGMENTAL AREA DOPAMINERGIC-NEURONS BY ACTIVATION OF SEROTONIN (5-HT)(1A) RECEPTORS - WAY 100,635-REVERSIBLE ACTIONS OF THE HIGHLY SELECTIVE LIGANDS, FLESINOXAN AND S-15535

      Synapse
    66. HJORTH S; KULLBERG A; MILLAN MJ; BENGTSSON HJ
      ALPHA(1)-ADRENOCEPTOR 5-HYDROXYTRYPTAMINE (5-HT1A) AUTORECEPTOR MEDIATION OF THE 5-HT RELEASE-REDUCING ACTION OF CLOZAPINE AND S16924 IN RAT VENTRAL HIPPOCAMPUS/

      Nordic journal of psychiatry
    67. GOBERT A; RIVET JM; AUDINOT V; NEWMANTANCREDI A; CISTARELLI L; MILLAN MJ
      SIMULTANEOUS QUANTIFICATION OF SEROTONIN, DOPAMINE AND NORADRENALINE LEVELS IN SINGLE FRONTAL-CORTEX DIALYSATES OF FREELY-MOVING RATS REVEALS A COMPLEX PATTERN OF RECIPROCAL AUTO-MEDIATED AND HETERORECEPTOR-MEDIATED CONTROL OF RELEASE

      Neuroscience
    68. CRISP GT; MILLAN MJ
      CONJUGATE ADDITION OF AMINO-ACID SIDE-CHAINS TO ALKYNONES AND ALKYNOIC ACID-DERIVATIVES

      Tetrahedron
    69. CRISP GT; MILLAN MJ
      CONJUGATE ADDITION OF AMINO-ACID SIDE-CHAINS TO DYES CONTAINING ALKYNONE, ALKYNOIC ESTER AND ALKYNOIC AMIDE LINKER ARMS

      Tetrahedron
    70. MILLAN MJ; DEKEYNE A; GOBERT A
      SEROTONIN (5-HT)(2C) RECEPTORS TONICALLY INHIBIT DOPAMINE (DA) AND NORADRENALINE (NA), BUT NOT 5-HT, RELEASE IN THE FRONTAL-CORTEX IN-VIVO

      Neuropharmacology
    71. SPEDDING M; NEWMANTANCREDI A; MILLAN MJ; DACQUET C; MICHEL AN; JACOBY E; VICKERY B; TALLENTIRE D
      INTERACTION OF THE ANXIOGENIC AGENT, RS-30199, WITH 5-HT1A RECEPTORS - MODULATION OF SEXUAL-ACTIVITY IN THE MALE-RAT

      Neuropharmacology
    72. BENGTSSON HJ; KULLBERG A; MILLAN MJ; HJORTH S
      THE ROLE OF 5-HT1A AUTORECEPTORS AND ALPHA(1)-ADRENOCEPTORS IN THE MODULATION OF 5-HT RELEASE - III - CLOZAPINE AND THE NOVEL PUTATIVE ANTIPSYCHOTIC S-16924

      Neuropharmacology
    73. NEWMANTANCREDI A; NICOLAS JP; AUDINOT V; GAVAUDAN S; VERRIELE L; TOUZARD M; CHAPUT C; RICHARD N; MILLAN MJ
      ACTIONS OF ALPHA(2) ADRENOCEPTOR LIGANDS AT ALPHA(2A) AND 5-HT1A RECEPTORS - THE ANTAGONIST, ATIPAMEZOLE, AND THE AGONIST, DEXMEDETOMIDINE,ARE HIGHLY SELECTIVE FOR ALPHA(2A) ADRENOCEPTORS

      Naunyn-Schmiedeberg's archives of pharmacology
    74. NEWMANTANCREDI A; VERRIELE L; CHAPUT C; MILLAN MJ
      LABELING OF RECOMBINANT HUMAN AND NATIVE RAT SEROTONIN 5-HT1A RECEPTORS BY A NOVEL, SELECTIVE RADIOLIGAND, [H-3]-S-15535 - DEFINITION OF ITS BINDING PROFILE USING AGONISTS, ANTAGONISTS AND INVERSE AGONISTS

      Naunyn-Schmiedeberg's archives of pharmacology
    75. MILLAN MJ; NEWMANTANCREDI A; BROCCO N; GOBERT A; LEJEUNE F; AUDINOT V; RIVET JM; SCHREIBER R; DEKEYNE A; SPEDDING M; NICOLAS JP; PEGLION JL
      S-18126 4-(2,3-DIHYDROBENZO[1,4]DIOXIN-6-YL)PIPERAZIN-1-YL METHYL]INDAN-2-YL)), A POTENT, SELECTIVE AND COMPETITIVE ANTAGONIST AT DOPAMINE D-4 RECEPTORS - AN IN-VITRO AND IN-VIVO COMPARISON WITH L-745,870 YL]PIPERAZIN-1-YL)METHYL-1H-PYRROLO[2,3B]PYRIDINE) AND RACLOPRIDE

      The Journal of pharmacology and experimental therapeutics
    76. AUDINOT V; NEWMANTANCREDI A; GOBERT A; RIVET JM; BROCCO M; LEJEUNE F; GLUCK L; DESPOSTE I; BERVOETS K; DEKEYNE A; MILLAN MJ
      A COMPARATIVE IN-VITRO AND IN-VIVO PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL DOPAMINE D-3 RECEPTOR ANTAGONISTS (-S-14297, NAFADOTRIDE, GR-103,691 AND U-99194())

      The Journal of pharmacology and experimental therapeutics
    77. MILLAN MJ; GOBERT A; NEWMANTANCREDI A; AUDINOT V; LEJEUNE F; RIVET JM; CUSSAC D; NICOLAS JP; MULLER O; LAVIELLE G
      S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - I - RECEPTORIAL AND NEUROCHEMICAL PROFILE COMPARISON WITH CLOZAPINE AND HALOPERIDOL

      The Journal of pharmacology and experimental therapeutics
    78. MILLAN MJ; SCHREIBER R; DEKEYNE A; RIVET JM; BERVOETS K; MAVRIDIS M; SEBBAN C; MAURELREMY S; NEWMANTANCREDI A; SPEDDING M; MULLER O; LAVIELLE G; BROCCO M
      S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL, POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - II - FUNCTIONAL PROFILE IN COMPARISON TO CLOZAPINE AND HALOPERIDOL

      The Journal of pharmacology and experimental therapeutics
    79. NEWMANTANCREDI A; GAVAUDAN S; CONTE C; CHAPUT C; TOUZARD M; VERRIELE L; AUDINOT V; MILLAN MJ
      AGONIST AND ANTAGONIST ACTIONS OF ANTIPSYCHOTIC AGENTS AT 5-HT1A RECEPTORS - A [S-35] GTP-GAMMA-S BINDING STUDY

      European journal of pharmacology
    80. MILLAN MJ; BROCCO M; VEIGA S; CISTARELLI L; MELON C; GOBERT A
      WAY-100,635 ENHANCES BOTH THE ANTIDEPRESSANT ACTIONS OF DULOXETINE AND ITS INFLUENCE ON DIALYSATE LEVELS OF SEROTONIN IN FRONTAL-CORTEX

      European journal of pharmacology
    81. PEGLION JL; VIAN J; GOUMENT B; DESPAUX N; AUDINOT V; MILLAN MJ
      TETRACYCLIC ANALOGS OF [-S14297 - SYNTHESIS AND DETERMINATION OF AFFINITY AND SELECTIVITY AT CLONED HUMAN DOPAMINE D-3 VS D-2 RECEPTORS(])

      Bioorganic & medicinal chemistry letters
    82. NEWMANTANCREDI A; CONTE C; CHAPUT C; VERRIELE L; MILLAN MJ
      AGONIST AND INVERSE AGONIST EFFICACY AT HUMAN RECOMBINANT SEROTONIN 5-HT1A RECEPTORS AS A FUNCTION OF RECEPTOR - G-PROTEIN STOICHIOMETRY

      Neuropharmacology
    83. MILLAN MJ; GIRARDON S; BERVOETS K
      8-OH-DPAT-INDUCED SPONTANEOUS TAIL-FLICKS IN THE RAT ARE FACILITATED BY THE SELECTIVE SEROTONIN (5-HT)(2C) AGONIST, RO-60-0175 - BLOCKADE OF ITS ACTIONS BY THE NOVEL 5-HT2C RECEPTOR ANTAGONIST SE-206,553

      Neuropharmacology
    84. NEWMANTANCREDI A; CONTE C; CHAPUT C; VERRIELE L; AUDINOTBOUCHEZ V; LOCHON S; LAVIELLE G; MILLAN MJ
      AGONIST ACTIVITY OF ANTIMIGRAINE DRUGS AT RECOMBINANT HUMAN 5-HT1A RECEPTORS - POTENTIAL IMPLICATIONS FOR PROPHYLACTIC AND ACUTE THERAPY

      Naunyn-Schmiedeberg's archives of pharmacology
    85. MILLAN MJ; NEWMANTANCREDI A; RIVET JM; BROCCO M; LACROIX P; AUDINOT V; CISTARELLI L; GOBERT A
      S-15535, A NOVEL BENZODIOXOPIPERAZINE LIGAND OF SEROTONIN (5-HT)(1A) RECEPTORS .1. INTERACTION WITH CLONED HUMAN (H)5-HT1A, DOPAMINE HD(2) HD(3) AND H-ALPHA(2A)-ADRENERGIC RECEPTORS IN RELATION TO MODULATION OF CORTICAL MONOAMINE RELEASE AND ACTIVITY IN MODELS OF POTENTIAL ANTIDEPRESSANT ACTIVITY/

      The Journal of pharmacology and experimental therapeutics
    86. MILLAN MJ; HJORTH S; SAMANIN R; SCHREIBER R; JAFFARD R; DELADONCHAMPS B; VEIGA S; GOUMENT B; PEGLION JL; SPEDDING M; BROCCO M
      S-15535, A NOVEL BENZODIOXOPIPERAZINE LIGAND OF SEROTONIN (5-HT)(1A) RECEPTORS .2. MODULATION OF HIPPOCAMPAL SEROTONIN RELEASE IN RELATION TO POTENTIAL ANXIOLYTIC PROPERTIES

      The Journal of pharmacology and experimental therapeutics
    87. LEJEUNE F; NEWMANTANCREDI A; AUDINOT V; MILLAN MJ
      INTERACTIONS OF (-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN AND (-)-8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN AND 7-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN AT HUMAN (H)D-3, HD(2) AND H-SEROTONIN(1A) RECEPTORS AND THEIR MODULATION OF THE ACTIVITY OF SEROTONINERGIC AND DOPAMINERGIC-NEURONS IN RATS())

      The Journal of pharmacology and experimental therapeutics
    88. GOBERT A; RIVET JM; CISTARELLI L; MELON C; MILLAN MJ
      ALPHA(2)-ADRENERGIC RECEPTOR BLOCKADE MARKEDLY POTENTIATES DULOXETINE-INDUCED AND FLUOXETINE-INDUCED INCREASES IN NORADRENALINE, DOPAMINE, AND SEROTONIN LEVELS IN THE FRONTAL-CORTEX OF FREELY MOVING RATS

      Journal of neurochemistry
    89. GOBERT A; RIVET JM; CISTARELLI L; MILLAN MJ
      POTENTIATION OF THE FLUOXETINE-INDUCED INCREASE IN DIALYSATE LEVELS OF SEROTONIN (5-HT) IN THE FRONTAL-CORTEX OF FREELY MOVING RATS BY COMBINED BLOCKADE OF 5-HT1A AND 5-HT1B RECEPTORS WITH WAY-100,635 AND GR-127,935

      Journal of neurochemistry
    90. GOBERT A; RIVET JM; CISTARELLI L; MILLAN MJ
      BUSPIRONE ENHANCES DULOXETINE-INDUCED AND FLUOXETINE-INDUCED INCREASES IN DIALYSATE LEVELS OF DOPAMINE AND NORADRENALINE, BUT NOT SEROTONIN, IN THE FRONTAL-CORTEX OF FREELY MOVING RATS

      Journal of neurochemistry
    91. AUDINOT V; LOCHON S; NEWMANTANCREDI A; LAVIELLE G; MILLAN MJ
      BINDING PROFILE OF THE NOVEL 5-HT1B 1D RECEPTOR ANTAGONIST, [H-3] GR-125,743, IN GUINEA-PIG BRAIN - A COMPARISON WITH [H-3] 5-CARBOXAMIDOTRYPTAMINE/

      European journal of pharmacology
    92. MILLAN MJ; PEGLION JL; LAVIELLE G; PERRINMONNEYRON S
      5-HT2C RECEPTORS MEDIATE PENILE ERECTIONS IN RATS - ACTIONS OF NOVEL AND SELECTIVE AGONISTS AND ANTAGONISTS

      European journal of pharmacology
    93. MILLAN MJ; GRESSIER H; BROCCO M
      THE DOPAMINE-D-3-RECEPTOR ANTAGONIST, (-S-14297, BLOCKS THE CATALEPTIC PROPERTIES OF HALOPERIDOL IN RATS())

      European journal of pharmacology
    94. MILLAN MJ; PERRINMONNEYRON S
      POTENTIATION OF FLUOXETINE-INDUCED PENILE ERECTIONS BY COMBINED BLOCKADE OF 5-HT1A AND 5-HT1B RECEPTORS

      European journal of pharmacology
    95. NEWMANTANCREDI A; AUDINOTBOUCHEZ V; GOBERT A; MILLAN MJ
      NORADRENALINE AND ADRENALINE ARE HIGH-AFFINITY AGONISTS AT DOPAMINE D-4 RECEPTORS

      European journal of pharmacology
    96. MORRIS BJ; NEWMANTANCREDI A; AUDINOT V; SIMPSON CS; MILLAN MJ
      INDUCTION OF C-FOS EXPRESSION IN CULTURED RAT STRIATAL NEURONS BY ACTIVATION OF DOPAMINE D-3 RECEPTORS

      British Journal of Pharmacology
    97. MILLAN MJ; GOBERT A
      AUTORECEPTOR AND HETEROCEPTOR CONTROL OF 5-HT, DOPAMINE (DA) AND NORADRENALINE (NAD) RELEASE IN FRONTAL-CORTEX - STRATEGIES FOR IMPROVED ANTIDEPRESSANT AGENTS

      British Journal of Pharmacology
    98. NEWMANTANCREDI A; CONTE C; CHAPUT C; SPEDDING M; MILLAN MJ
      INHIBITION OF THE CONSTITUTIVE ACTIVITY OF HUMAN 5-HT1A-RECEPTORS BY THE INVERSE AGONIST, SPIPERONE BUT NOT THE NEUTRAL ANTAGONIST, WAY-100635

      British Journal of Pharmacology
    99. NEWMANTANCREDI A; VERRIELE L; CHAPUT C; MILLAN MJ
      DOWN-REGULATION OF RAT BETA-ADRENOCEPTORS BY CLENBUTEROL OR DESIPRAMINE DOES NOT REQUIRE CHRONIC TREATMENT - [H-3] CGP-12177 BINDING REVEALS RAPID (24-HOUR) MODULATION

      Brain research bulletin
    100. NEWMANTANCREDI A; CHAPUT C; VERRIELE L; MILLAN MJ
      CLOZAPINE IS A PARTIAL AGONIST AT CLONED, HUMAN SEROTONIN 5-HT1A RECEPTORS

      Neuropharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/01/21 alle ore 07:40:51